BioCryst Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 21.79 M | $165.39 M | 6.07% | 10.42% |
| BLACKROCK, INC. | 11/12/2025 | 21.25 M | $161.26 M | -0.84% | 10.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 12.17 M | $92.36 M | 159.36% | 5.82% |
| STATE STREET CORP | 11/14/2025 | 9.81 M | $74.44 M | 15.31% | 4.69% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 9.39 M | $71.27 M | 10.95% | 4.49% |
| UBS GROUP AG | 11/13/2025 | 5.97 M | $45.30 M | 6.29% | 2.85% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2025 | 5.46 M | $41.47 M | -4.38% | 2.61% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 5.23 M | $39.67 M | 22.14% | 2.50% |
| MORGAN STANLEY | 11/14/2025 | 5.20 M | $39.49 M | -2.38% | 2.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 5.05 M | $38.35 M | -0.05% | 2.42% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 4.42 M | $33.54 M | 3.06% | 2.11% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 4.24 M | $32.19 M | 0.29% | 2.03% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 3.62 M | $27.48 M | 191.03% | 1.73% |
| NUVEEN, LLC | 11/12/2025 | 3.62 M | $27.46 M | 2.36% | 1.73% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 3.09 M | $23.47 M | -14.58% | 1.48% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 2.71 M | $20.58 M | -23.05% | 1.30% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 2.63 M | $19.98 M | -5.38% | 1.26% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 2.41 M | $18.29 M | 1.55% | 1.15% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 2.20 M | $16.68 M | -16.23% | 1.05% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.14 M | $16.25 M | -15.28% | 1.02% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 2.09 M | $15.90 M | 43.75% | 1.00% |
| JUPITER ASSET MANAGEMENT LTD | 11/10/2025 | 2.06 M | $15.60 M | -1.06% | 0.98% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.99 M | $15.14 M | 1.25% | 0.95% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.90 M | $14.44 M | -33.03% | 0.91% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.89 M | $14.36 M | -1.13% | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 1.88 M | $14.27 M | -8.73% | 0.90% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.85 M | $14.03 M | 563.68% | 0.88% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 1.82 M | $13.84 M | -0.02% | 0.87% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.71 M | $12.97 M | -61.06% | 0.82% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 1.37 M | $10.43 M | 13.74% | 0.66% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.36 M | $10.32 M | -46.83% | 0.65% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 1.25 M | $9.49 M | -72.22% | 0.60% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 1.25 M | $9.46 M | 100.00% | 0.60% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.20 M | $9.03 M | 23.45% | 0.57% |
| SEGALL BRYANT & HAMILL, LLC | 11/12/2025 | 1.13 M | $8.61 M | -6.99% | 0.54% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.13 M | $8.59 M | -28.52% | 0.54% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 1.11 M | $8.41 M | 53.27% | 0.53% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.07 M | $8.11 M | 129.49% | 0.51% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 1.01 M | $7.69 M | 0.46% | 0.48% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 999.79 K | $7.59 M | -12.97% | 0.48% |
| INVESCO LTD. | 11/13/2025 | 962.38 K | $7.30 M | -3.10% | 0.46% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 957.02 K | $7.26 M | -61.32% | 0.46% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 924.78 K | $7.02 M | -31.35% | 0.44% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 901.50 K | $6.84 M | 100.00% | 0.43% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 848.56 K | $6.44 M | -32.53% | 0.41% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 839.40 K | $6.36 M | 125.78% | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 800.00 K | $6.07 M | 0.00% | 0.38% |
| BARCLAYS PLC | 11/12/2025 | 782.23 K | $5.94 M | -2.72% | 0.37% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 734.99 K | $5.58 M | 1.03% | 0.35% |
| MARSHALL WACE, LLP | 11/13/2025 | 731.41 K | $5.55 M | 410.36% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioCryst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 387 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 21.79 M
BlackRock, Inc.: 21.25 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 12.17 M
STATE STREET CORP: 9.81 M
Kynam Capital Management, LP: 9.39 M
UBS Group AG: 5.97 M
92.80% of BioCryst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 234.74 M shares in the last 24 months. This purchase volume represents approximately $1.78 B in transactions.